drugset / Trial / NCT00630474
Nasal Decongestion and Obstructive Sleep Apnea
RandomizedCrossoverTriple-blindTreatment
Summary
Whether impaired nasal breathing contributes to sleep related breathing disturbances has not been known. Therefore, the purpose of the study is to compare the effect of xylometazoline, a drug that decongests the nasal mucosa when applied locally, with placebo in terms of sleep and nocturnal breathing and daytime performance.
Timeline
- Start
- 2004-01
- Primary completion
- 2005-04
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Xylometazoline | Small molecule | 0.1 % | Intranasal |
| Comparator | Xylometazoline | Small molecule | 0.15 mg | Intranasal |